Discontinued — last reported Q3 '23
Tapestry, Inc. Equity Method Investments decreased by 1.6% to $6.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 376.9%, from $1.30M to $6.20M. Over 3 years (FY 2021 to FY 2024), Equity Method Investments shows an upward trend with a 135.1% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.00K | $100.00K | $100.00K | $100.00K | $100.00K | $100.00K | $100.00K | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M | $1.30M | $6.30M | $6.30M | $6.20M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | >999% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +384.6% | +0.0% | -1.6% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | >999% | >999% | >999% | >999% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +384.6% | +384.6% | +376.9% |